A 52-year-old woman with obesity and type 2 diabetes has elevated liver enzymes and ultrasound evidence of hepatic steatosis. Viral hepatitis serology is negative, and there is no significant alcohol use. According to contemporary guidance, what is the cornerstone of management for non-alcoholic fatty liver disease (NAFLD)?